medigraphic.com
ISSN 1561-3054 (Electronic)

2013, Number 2

<< Back Next >>

Rev Cubana Med Trop 2013; 65 (2)

Update on Borrelia burgdorferi sensu lato and Lyme disease

Rodríguez GI

Language: Spanish
References: 77
Page: 149-165
PDF size: 86.69 Kb.


ABSTRACT

Introduction: Borrelia burgdorferi sensu lato is the causative agent of Lyme disease, an emerging zoonosis, whose diagnosis, prevention and control are difficult and it is mainly reported in the northern hemisphere.
Objective: to provide updated information about Borrelia burgdorferi.
Methods: a review of scientific and specialized literature on the key aspects of this agent and the disease such as characteristics and life cycle of borrelias, epidemiology, clinical manifestations in humans, laboratory diagnosis, current case definition, treatment, prophylaxis, prevention and control.
Results: current valuable information on selected items was set forth, which is useful for the personnel involved in vector-borne infectious diseases. Additionally, information about studies conducted in Cuba was provided.
Conclusions: this paper offers updated information for the epidemiological, clinical and microbiological management of suspected cases of infection with Borrelia burgdorferi sensu lato.


REFERENCES

  1. Steere AC. Lyme disease. N Engl J Med. 2001;345(2):115-25.

  2. Heyman P, Cochez C, Hofhuis A, Van der Giessen J, Sprong H, Porter SR, et al. A clear and present danger: tick-borne disease in Europe. Expert Rev Anti Infect Ther. 2010;8(1):33-50.

  3. Rudenko N, Golovchenko M, Grubhoffer L, Oliver JH. Borrelia carolinensis sp. nov., a new (14th) member of the Borrelia burgdorferi sensu lato complex from the Southeastern region of the United States. J Clin Microbiol. 2009;47(1):134-41.

  4. Rudenko N, Golovchenko M, Lin T, Gao L, Grubhoffer L, Oliver JH. Delineation of a new species of the Borrelia burgdorferi sensu lato complex, Borrelia americana sp. nov. J Clin Microbiol. 2009;47(12):3875-80.

  5. Margos G, Vollmer SA, Cornet M, Garnier M, Fingerle V, Wilske B, et al. A new Borrelia species defined by multilocus sequence analysis of housekeeping genes. Appl Environ Microbiol. 2009;75(16):5410-6.

  6. Casjens SR, Fraser-Liggett CM, Mongodin EF, Qiu WG, Dunn JJ, Luft BJ, et al. Whole genome sequence of an unusual Borrelia burgdorferi sensu lato isolate. J Bacteriol. 2011;193(6):1489-90.

  7. Stanek G, Wormser G, Gray J, Strle F. Lyme borreliosis. Lancet. 2012;379(9814):461-73.

  8. Steere AC. Borrelia burgdorferi (Lyme disease, Lyme borreliosis). En: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett's Principles and practice of infectious diseases. 6 ed. USA: Elsevier Inc; 2005. p. 2798-809.

  9. Krupka M, Raska M, Belakova J, Horynova M, Novotny R, Weigl E. Biological aspects of Lyme disease spirochetes: unique bacteria of the Borrelia burgdorferi species group. Biomed Pap Med Fac Univ Palacky Olomouc Czeck Repub. 2007;151(2):175-86.

  10. Brooks GF, Carroll KC, Butel JS, Morse SA. Spirochetes and other spiral microorganisms. En: Jawetz, Melnick, & Adelberg's Medical Microbiology. 24 ed. McGraw-Hill Education; 2007[cited 22 Abr 2011]. Available at: http://www.accessmedicine.com

  11. Tilly K, Rosa PA, Stewart PE. Biology of infection with Borrelia burgdorferi. Infect Dis Clin N Am. 2008;22(2):217-34.

  12. Marques AR. Lyme disease: a review. Curr Allergy Asthma Rep. 2010;10(1): 13-20.

  13. Baril C, Richaud C, Baranton G, Saint Girons I. Linear chromosome of Borrelia burgdorferi. Res Microbiol. 1989;140(8):507-16.

  14. Fraser CM, Casjens S, Huang WM, Sutton GG, Clayton R, Lathigra R, et al. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature. 1997;390(11):580-6.

  15. Davidson BE, MacDougall J, Saint Girons I. Physical map of the linear chromosome of the bacterium Borrelia burgdorferi 212, a causative agent of Lyme disease, and localization of rRNA genes. J Bacteriol. 1992;174(11):3766-74.

  16. Schwartz JJ, Gazumyan A, Schwartz I. rRNA gene organization in the Lyme disease spirochete, Borrelia burgdorferi. J Bacteriol. 1992;174(11):3757-65.

  17. Ojaimi C, Davidson BE, Saint Girons I, Old IG. Conservation of gene arrangement and an unusual organization of rRNA genes in the linear chromosomes of the Lyme disease spirochaetes Borrelia burgdorferi, B. garinii and B. afzelii. Microbiol. 1994;140(Pt11):2931-40.

  18. Fukunaga M, Yanagihara Y, Sohnaka M. The 23S/5S ribosomal RNA genes (rrl/rrf) are separate from the 16S ribosomal RNA gene (rrs) in Borrelia burgdorferi, the aetiological agent of Lyme disease. J Gen Microbiol. 1992;138(5):871-7.

  19. Steere AC. Lyme borreliosis in 2005, 30 years after initial observations in Lyme Connecticut. Wien Klin Wochenschr. 2006;118(21-22):625-33.

  20. Mursic VP, Wanner G, Reinhardt S, Wilske B, Busch U, Marget W. Formation and cultivation of Borrelia burgdorferi spheroplast-L-form variants. Infection. 1996;24(3):218-26.

  21. Gruntar I, Malovrh T, Murgia R, Cinco M. Conversion of Borrelia garinii cystic forms to motile spirochetes in vivo. APMIS. 2001;109(5):383-8.

  22. Murgia R, Piazzetta C, Cinco M. Cystic forms of Borrelia burgdorferi sensu lato: induction, development, and the role of RpoS. Wien Klin Wochenschr. 2002;114(13-14):574-9.

  23. Miklossy J, Kasas S, Zurn AD, McCall S, Yu S, McGeer PL. Persisting atypical and cystic forms of Borrelia burgdorferi and local inflammation in Lyme neuroborreliosis. J Neuroinflammation. 2008;5(40):1-18.

  24. Gern L. Tiques et borréliose de Lyme en Suisse occidentale. Bull Soc Neuchateloise Scie Nat. 2004;127(1):5-21.

  25. Centers for Disease Control and Prevention. Surveillance for Lyme disease- United States, 1992-2006. MMWR Morb Mortal Wkly Rep. 2008;57(10):1-9.

  26. Hubálek Z. Epidemiology of Lyme disease. Curr Probl Dermatol. 2009;37: 31-50.

  27. Comstedt P, Asokliene L, Eliasson I, Olsen B, Wallensten A, Bunikis J, et al. Complex population structure of Lyme Borreliosis Group Spirochete Borrelia garinii in Subarctic Eurasia. PLos ONE. 2009;4(6):1-9.

  28. Stanchi NO, Balague LJ. Lyme disease: antibodies against Borrelia burgdorferi in farm workers in Argentina. Rev Saude Publica. 1993;27(4):305-7.

  29. Ciceroni L, Bartoloni A, Guglielmetti P, Paradisi F, Gamboa-Barahona H, Roselli M, et al. Prevalence of antibodies to Borrelia burgdorferi, Borrelia parkeri and Borrelia turicatae in human settlements of the Cordillera Province, Bolivia. J Trop Med Hyg. 1994;97(1):13-7.

  30. Neira O, Cerda C, Alvarado MA, Palma S, Abumohor P, Wainstein E, et al. Lyme disease in Chile. Prevalence study in selected groups. Rev Med Chil. 1996;124(5):537-44.

  31. Osorio G. Búsqueda de la espiroqueta Borrelia burgdorferi sensu lato mediante PCR en garrapatas ixoideas chilenas silvestres. Rev Med Chil. 2001;129(3):270-6.

  32. Palacios R, Osorio LE, Giraldo LE, Torres AJ, Philipp MT, Ochoa MT. Positive IgG Western blot for Borrelia burgdorferi in Colombia. Mem Inst Oswaldo Cruz. 1999;94(4):499-503.

  33. Arocha-Sandoval F, Amesty-Valbuena A, Urbina M, Durango AI, Vargas-Montiel H. Detección de anticuerpos a Borrelia burgdorferi en una muestra de la población del estado de Zulia. Invest Clin. 1994;35(2):91-104.

  34. Mantovani E, Costa IP, Gauditano G, Bonoldi VLN, Higuchi ML, Yoshinari NH. Description of Lyme disease-like syndrome in Brazil. It is a new tick borne disease or Lyme disease variation? Brazilian J Med Biol Res. 2007;40(4):443-56.

  35. Gordillo-Pérez G, Torres J, Solórzano-Santos F, De Martino S, Lipsker D, Velázquez E, et al. Borrelia burgdorferi infection and cutaneous Lyme disease, Mexico. Emerg Infect Dis. 2007;13(10):1556-8.

  36. Gordillo-Pérez G, Vargas M, Solórzano-Santos F, Rivera A, Polaco OJ, Alvarado L, et al. Demonstration of Borrelia burgdorferi sensu stricto infection in ticks from the northeast of Mexico. Clin Microbiol Infect. 2009;15(5):496-8.

  37. Rodríguez I, Fernández C, Cinco M, Pedroso R, Fuentes O. Do antiborrelial antibodies suggest Lyme disease in Cuba? Emerg Infec Dis. 2004;10(9):1698-9.

  38. Rodríguez I, Ortega LM, Fernández C, Rodríguez ME, Scheurer C, Lienhard R. Borreliosis de Lyme en Cuba. A propósito de nuevos casos. Rev Panam Infectol. 2009;11(3):37-41.

  39. Rodríguez I, Fernández C, Sánchez L, Martínez B, Siegrist HH, Lienhard R. Prevalence of antibodies to Borrelia burgdorferi sensu stricto in humans from a Cuban village. Braz J Infec Dis. 2012;16(1):82-5.

  40. Cinco M, Barbone F, Grazia-Ciufolini M, Mascioli M, Anguero-Rosenfeld, Stefanel P, et al. Seroprevalence of tick-borne infections in forestry rangers from northeastern Italy. Clin Microbiol Infect. 2004;10(12):1056-61.

  41. Killilea ME, Swei A, Lane RS, Briggs CJ, Ostfeld RS. Spatial dynamics of Lyme disease: a review. Ecohealth. 2008;5(2):167-95.

  42. Bratton RL, Whiteside JW, Hovan MJ, Engle RL, Edwards FD. Diagnosis and treatment of Lyme disease. Mayo Clin Proc. 2008;83(5):566-71.

  43. Steere AC, Coburn J, Glickstein L. The emergence of Lyme disease. J Clin Invest. 2004;113(8):1093-101.

  44. Zakovska A, Nejedla P, Holikova A, Dendis M. Positive findings of Borrelia burgdorferi in Culex (Culex) pipiens pipiens larvae in the surrounding of Brno city determined by the PCR method. Ann Agric Environ Med. 2002;9(2):257-9.

  45. Kosik-Bogacka D, Kuzna-Grygiel W, Bukowska K. The prevalence of spirochete Borrelia burgdorferi sensu lato in ticks Ixodes ricinus and mosquitoes Aedes spp. within a selected recreational area in the city of Szczecin. Ann Agric Environ Med. 2004;11(1):105-8.

  46. Magnarelli LA, Anderson JF. Ticks and biting insects infected with the etiologic agent of Lyme disease, Borrelia burgdorferi. J Clin Microbiol. 1988;26(8):1482-6.

  47. Derdáková, M, Lencáková D. Association of genetic variability within the Borrelia burgdorferi sensu lato with the ecology, epidemiology of Lyme borreliosis in Europe. Ann Agric Environ Med. 2005;12(2):165-72.

  48. Sigal LH. Lyme disease: a world-wide borreliosis. Clin Exp Rheumatol. 1988;6(4):411-21.

  49. Kugeler KJ, Griffith KS, Gould LH, Kochanek K, Delorey MJ, Biggerstaff BJ, et al. A review of death certificates listing Lyme disease as a cause of death in the United States. Clin Infect Dis. 2011;52(3):364-7.

  50. Amer R, Brannan S, Forrester JV. Inflammatory choroidal neovascular membrane in presumed ocular Lyme borreliosis. Acta Ophthalmol. 2009;87(3): 346-8.

  51. Evison J, Aebi C, Francioli P, Péter O, Bassetti S, Gervaix A, et al. Borréliose de Lyme. 1ere partie: Epidémiologie et diagnostic. Rev Med Suisse. 2006;2(60): 919-24.

  52. Steere AC, Sikand VK, Schoen RT, Nowakowski J. Asymptomatic infection with Borrelia burgdorferi. Clin Infect Dis. 2003;37(4):528-32.

  53. Hercogova J, Vanousova D. Syphilis and borreliosis during pregnancy. Dermatol Therapy. 2008;21(3):205-9.

  54. Wilske B. Epidemiology and diagnosis of Lyme borreliosis. Ann Med. 2005;37(8):568-79.

  55. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of Lyme borreliosis. Clin Microbiol Rev. 2005;18(3):484-509.

  56. Kelly R. Cultivation of Borrelia hermsii. Science. 1971;173(995):443-4.

  57. Barbour AG. Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med. 1984;57(4):521-5.

  58. Pollack RJ, Telford III SR, Spielman A. Standardization of medium for culturing Lyme disease spirochetes. J Clin Microbiol. 1993;31(5):1251-5.

  59. Preac-Mursik V, Wilske B, Schierz G. European Borrelia burgdorferi isolated from humans and ticks: culture conditions and antibiotic susceptibility. Zbl Bakt Hyg A. 1986;263(1-2):112-8.

  60. Ruzic-Sabljic E, Strle F. Comparison of growth of Borrelia afzelii, B. garinii, and B. burgdorferi sensu stricto in MKP and BSK-II medium. Inter J Med Microbiol. 2004;294(6):407-12.

  61. Schmidt BL. PCR in laboratory diagnosis of human Borrelia burgdorferi infections. Clin Microbiol Rev. 1997;10(1):185-201.

  62. Courtney JW, Kostelnik LM, Zeidner NS, Massung RF. Multiplex real-time PCR for detection of Anaplasma phagocytophilum and Borrelia burgdorferi. J Clin Microbiol. 2004;42(7):3164-8.

  63. Portnoi D, Sertour N, Ferquel E, Garnier M, Baranton G, Postic D. A single-run, real-time PCR for detection and identification of Borrelia burgdorferi sensu lato species, based on the hbb gene sequence. FEMS Microbiol Lett. 2006;259(1):35-40.

  64. Centers for Disease Control and Prevention. Lyme disease diagnosis; 2010 [cited 26 Mar 2011]. Available at: http://www.cdc.gov/ncidod/dvbid/lyme/ld_humandisease_diagnosis.htm

  65. Centers for Disease Control and Prevention. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morbid Mortal Weekly Rep. 1995;44(31):590-1.

  66. Binnicker MJ, Jespersen DJ, Harring JA, Rollins LO, Bryant SC, Beito EM. Evaluation of two commercial systems for the automated processing, reading and interpretation of Lyme Western blots. J Clin Microbiol. 2008;46(7):2216-21.

  67. Mogilyansky E, Loa CC, Adelson ME, Mordechai E, Tilton RC. Comparison of Western immunoblotting and the C6 Lyme antibody test for laboratory detection of Lyme disease. Clin Diagn Lab Immunol. 2004;11(5):924-9.

  68. Steere AC, McHughG, Damle N, Sikand VK. Prospective study of serologic tests for Lyme disease. Clin Infect Dis. 2008;47(2):188-95.

  69. Bergmann AR, Schmidt BL, Derler AM, Aberer E. Importance of sample preparation for molecular diagnosis of Lyme borreliosis from urine. J Clin Microbiol. 2002;40(12):4581-4.

  70. Centers for Disease Control and Prevention. Notice to readers: caution regarding testing for Lyme disease. MMWR Morb Mortal Wkly Rep. 2005;54(5):125.

  71. Centers for Disease Control and Prevention. Lyme disease (Borrelia burgdorferi). 2011 Case definition [cited 22 Abr 2011]. Available at: http://www.cdc.gov/osels/ph_surveillance /nndss/print/lyme_disease_current.htm

  72. Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Krause A, et al. Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect. 2011;17(1):69-79.

  73. Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43(1):1089-134.

  74. Evison J, Aebi C, Francioli P, Péter O, Bassetti S, Gervaix A, et al. Borréliose de Lyme. 2e partie: Clinique et traitement. Rev Med Suisse. 2006;2(60):925-34.

  75. Vanousová D, Hercogová J. Lyme borreliosis treatment. Dermatol Therapy. 2008;21(2):101-9.

  76. Wormser GP, O'Connell S. Treatment of infection caused by Borrelia burgdorferi sensu lato. Expert Rev Anti Infect Ther. 2011;9(2):245-60.

  77. Evison J, Aebi C, Francioli P, Péter O, Bassetti S, Gervaix A, et al. Borréliose de Lyme. 3e partie: Prévention, grossesse, états d'immunodéficience, syndrome postborréliose de Lyme. Rev Med Suisse. 2006;2(60):935-40




2020     |     www.medigraphic.com